Our Session Chairs and Speakers
We are delighted to have hosted prestigious speakers presenting interesting and thought-provoking talks with an integral focus on One Medicine to delegates.
Read more about our Chairs and Speakers below.
Founder’s Address: Professor Noel Fitzpatrick – The essence of One Medicine
Professor Noel Fitzpatrick MVB, DSc(Hon), DUniv CertSAO, CertVR, DipACVSMR, DipECVSMR, DSAS(Orth), MRCVS
Professor Fitzpatrick is an orthopaedic/neuro veterinary surgeon recognised and respected globally as a leader in his field of expertise. He is Managing Director of Fitzpatrick Referrals, a specialist veterinary referral hospital, employing more than 250 staff which he established over a decade ago, and operates from two centres in Surrey. He is also a founding partner of the University of Surrey’s School of Veterinary Medicine and has been instrumental in bringing the concept of One Medicine to the fore in the UK. Noel founded Humanimal Trust on 6 May 2014. As a vet, he experienced personally the deep divide between human and veterinary medicine and saw how unfair this was. Frustrated by the lack of opportunities to share what he was learning from day to day practice, or to benefit from relevant learning from human medicine, he decided to create the platform himself.
SESSION ONE - One Community, One Goal: One Medicine
Keynote: Helen Ballantyne - Nursing – The future of One Medicine
After graduating with a degree in Pharmacology in 2002, Helen qualified as a Registered Veterinary Nurse in 2005. She worked as a locum nurse nationally and internationally, gathering experience in referral medicine and surgery, charity practice, emergency nursing and exotics. Helen obtained a Post Graduate Diploma in Adult Nursing in 2013 and her current role is Clinical Nurse Specialist for Living Kidney Donation where she supports living kidney donors through the process of donation and organises kidney transplant surgeries. As part of this role, she also works a Transplant Coordinator managing the logistics of matching, retrieving and transplanting abdominal organs from deceased donors Helen remains a Registered Veterinary Nurse and has developed a strong interest in the principles of One Health and is the Chair of the UK One Health Coordination Group. She regularly lectures and writes about concepts and ways of working that may be shared between the professions to support clinical and professional practice. Her first textbook, Veterinary Nursing Care Plans: Theory and Practice was published in 2018. She has just completed her MSc in Healthcare Management and is looking for her next big project!
Katrina is a nurse who has worked in a range of UK health and civil service settings including the third sector. She has a specific interest in promoting an awareness and understanding of children’s palliative care and in ensuring children and families have access to high-quality care when they need it. Katrina was presented the Elisabeth Kübler-Ross Award for Outstanding Contribution was presented for her vision in developing the UK’s first Integrated Care Pathway for children’s palliative care. She retired from work in August 2019 and continued involvement in children’s palliative care policy and practice through the Royal College of Nursing and returned to frontline work with Public Health England during COVID-19. She is the Chair of the Association of British Paediatric Nurses; a trustee of Acorns Children’s Hospices and an Ambassador for the One Medicine charity Humanimal Trust and a Justice of the Peace.
Professor Roberto La Ragione BSc (Hons) MSc, PhD, FRSB CBiol, FIBMS, CSci, AECVM, FRCPATH, Hon. Assoc. RCVS - Chair of Trustees, Humanimal Trust
Talk: Antimicrobial resistance: A global One Medicine challenge
Roberto graduated in 1995 and then went on to study for a postgraduate degree in veterinary microbiology at the Royal Veterinary College (University of London). In 1996, he moved to the UK Government’s Veterinary Laboratories Agency (VLA) to undertake a PhD on the pathogenesis of E. coli in poultry. On completion of his PhD studies, Roberto commence a post-doctoral position at Royal Holloway, University of London, studying E. coli virulence factors and vaccine development. In 2005, Roberto was appointed Head of Pathogenesis and Control at the AHVLA and in 2010, was appointed Professor of Veterinary Microbiology and Pathology at the University of Surrey. He gained the FRCPath in 2010, and in 2012 was appointed the Associate Dean for Veterinary Strategy in the new School of Veterinary Medicine at the University of Surrey. In 2014, he was appointed to the position of Head of the Department of Pathology and Infectious Diseases and Director of the Veterinary Pathology Centre., In 2019, he was appointed Deputy Head of the School of Veterinary Medicine at the University of Surrey. He is the past President of the Med-Vet-Net Association and the Veterinary Research Club, a member of the Houghton Trust, a member of the APHA Science Advisory Board and the Chair of the Royal College of Pathologists, Veterinary Pathology SAC as well as being Chair of Humanimal Trust.
Dr Ben Marshall MBBS, FRCP, PhD, DTM&H - Trustee, Humanimal Trust
Talk: What can the COVID pandemic teach us about fully comprehending One Medicine?
Dr Ben Marshall is a consultant respiratory physician at the University Hospital Southampton NHS Foundation Trust. He has worked there for around 15 years and leads sub-specialist services in tuberculosis and interstitial lung diseases. His research interests also lie in these disease areas and he collaborates with scientists at the University of Southampton Faculty of Medicine and in the internationally renowned, National Institute of Health Science Respiratory Biomedical Research Unit (NIHR BRU) on a number of projects and themes working to identify the underlying pathophysiological mechanisms responsible for causing progressive lung damage. He plays an active role in the teaching of undergraduates at the Faculty of Medicine as well as in the teaching of postgraduate doctors and nurses. He now devotes 30% of his week to education and research and is passionate about the delivery of high-quality teaching and scientific discovery. Ben is also a Trustee of Humanimal Trust.
Mr Mike Uglow MBBS, FRCS (TR&ORTH) - Trustee, Humanimal Trust
Talk: One Medicine in relation to orthopaedics
Mike Uglow has been a consultant orthopaedic surgeon for 18 years, based at the University Hospital Southampton NHS Foundation Trust. Mike works as a specialist in children’s orthopaedics and is currently working in Abu Dhabi, UAE. He is a Trustee of Humanimal Trust.
Children’s orthopaedics deals with developmental and traumatic bone and joint disorders. Mike specialises in lower limb problems from the hip to the foot and has particular expertise in limb length and deformity correction especially that of the foot and ankle. His association with Humanimal Trust’s Founder, Professor Noel Fitzpatrick, arose from their mutual interest in the use of external fixators to correct limb deformities in humans and animals. Mike has published papers of several topics including clubfoot surgery and various aspects of orthopaedic trauma and is actively involved in ongoing research and education.
Dr Alexandra Dedman - Humanimal Trust Science Team
Talk: The One Medicine impact: A Humanimal Trust research impact update
Dr Alexandra Dedman is a freelance research and science writer who has worked regularly with Humanimal Trust since 2019. Alex is involved in developing the Humanimal Hub, an online community for human and animal health professionals. She loves finding out about new One Medicine research and talking to all of the Humanimal Hub members.
LUNCHTIME SESSION - PetMedix, Test and Treat, The One Health Company (FidoCure)
Dr Jolyon Martin - Co-Founder and Head of Business Development, PetMedixTM
PetMedixTM is a research and development stage biopharmaceutical company based in Cambridge, UK, developing antibody-based therapeutics for companion animals. The growing team have over 30 years’ experience building platforms that can develop species-specific therapeutic antibodies. Driven by the core value of improving the health and welfare of animals, PetMedixTM is taking the cutting edge of human medicine and using it to develop innovative new veterinary treatments against a wide range of clinical indications for dogs and for cats.
PetMedixTM is based on Jolyon's PhD work in the laboratory of Professor Allan Bradley FRS, who is CSO and co-founder of both PetMedixTM and Kymab Ltd. At PetMedixTM, Jolyon is responsible for external partnerships and licensing, and led the work to secure their recent partnership deal with Boehringer Ingelheim. He also works alongside the CEO and executive team to shape commercial strategy and the company’s future direction.
Balancing his studies at the University of Cambridge with an interest in start-ups and entrepreneurship, Jolyon worked with the founding team of Simprints for a year and also for Horizon Discovery in both Boston, MA and Cambridge, UK. He was named Cambridge Young Entrepreneur of the Year in 2017 and was a finalist in Onestart 2014. Jolyon is passionate about diversity and representation, and volunteers with the Beyond Equality Initiative - running workshops on tackling toxic masculinity in university sports teams."
Rachel Kirkby - Business Development Director, Test & Treat
Test & Treat Limited is based in Newmarket, UK and was formed in 2017 to develop and commercialise point of care tests for the rapid detection of urinary tract infections and subsequent antibiotic sensitivity analysis in veterinary and human clinical applications.
Rachel joined Test & Treat in July 2020 as Business Development Director. Rachel is a qualified veterinarian and graduated from the Royal Veterinary College, London in 2006. She has a postgraduate certificate in Small Animal Medicine and prior to joining Test & Treat, was the Clinical Director at a busy clinic in West London.
Christina Lopes MA - Founder and CEO, The One Health Company and Benjamin Lewis - Founder and Chief Strategy Officer, The One Health Company
Currently, cancer care for dogs lags behind cancer care for humans by approximately 20 years. FidoCure® developed by The One Health Company, introduces therapies that have been successfully used to treat cancer in humans into the world of veterinary medicine. FidoCure® works by using genomic testing to identify possible cancer-causing mutations and then suggests targeted therapy to precisely attack the cancer cells, therefore providing personalised medicine in the treatment of canine cancers.
Christina Lopes and Benjamin Lewis are the founders of The One Health Company based in San Francisco, USA, who are the providers of FidoCure® and who aim to provide cutting edge diagnostics and targeted therapies for dogs.
Christina Lopes is CEO and co-founder of The One Health Company and has been recognised as Young Global Leader by the World Economic Forum at Davos for her pioneering efforts in both deal making and women’s health. Christina was managing director of Cerberus Capital and advisory board director for International Planned Parenthood (Western Hemisphere). She also participated in The United Nations Commission for the Status of Women, and lectured at Columbia University and was honoured as a Rising Talent by the Women’s Forum in 2014. She holds a BA from the University of Massachusetts, a Masters in International and Political Affairs from Columbia University, and Doctoral Coursework in Ethics at Princeton University. She loves dogs and bringing access to cutting edge healthcare.
Benjamin Lewis is an animal health visionary, proud pet parent, and former Olympic athlete. As Chief Strategy Officer of The One Health Company, Benjamin is committed to advancing cancer cures for dogs. Formerly, he was the co-founder and CEO of 4Vets, the largest B2B distributor of animal health products in Brazil. Benjamin also represented the United States in the 2004 Olympics in Athens, Greece, where he served as captain of the K4. He studied bioengineering at Dartmouth College where he was inducted in the Dartmouth Hall of Fame (Wearer of the Green). In addition, he studied veterinary medicine at the University of Pennsylvania School of Veterinary Medicine, and Health Care Management at the Wharton School of Business.
SESSION TWO - One Medicine in action
Dr Tracey King MRSB, CSci - Research & Outreach Manager, Humanimal Trust
Tracey is a Chartered Scientist with a career background spanning administration, laboratory and project management having worked in various sectors including the University of Oxford, local government and the BBC. Tracey joined Humanimal Trust in August 2020 having previously worked as a scientific and technical adviser for ornamental aquatics. Her research background is in parasitology and she is considered a founder member of Cardiff University’s parasitology research group CRIPES (Cardiff Research into Infection and Parasites in Ecological Systems). She is a member of the Royal Society of Biology and the Association of Research Managers and Administrators.
Professor Joanna Morris and Dr Tomoko Iwata
Talk 1: A blood test for bladder cancer diagnosis and monitoring
Talk 2: A blood test for bladder cancer diagnosis and monitoring
Professor Joanna Morris - University of Glasgow
Professor Joanna Morris is Professor of Veterinary Oncology (Small Animal Clinical Sciences) at the University of Glasgow. Professor Morris’ clinical research interests include mammary tumours in cats and dogs and the identification of serum biomarkers in other tumour types, such as bladder cancer.
Dr Tomoko Iwata - University of Glasgow
Dr Tomoko Iwata is a Senior Lecturer (Medicine) whose research interests are in the mechanisms of bladder cancer progression and immunotherapy response.
Professor Matthew Allen - University of Cambridge
Talk: Evaluation of a metastasis signature for determining rate of disease progression in osteosarcoma
Professor Matthew Allen is Professor of Small Animal Surgery in the Department of Veterinary Medicine, University of Cambridge. Professor Allen’s research interests include musculoskeletal oncology (bone cancer), bone regeneration and implant fixation, musculoskeletal biomechanics and orthopaedic infection. Professor Allen is clinically active in the area of total joint replacement and is interested in developing translational comparative research collaborations between the veterinary school and the medical school at the University of Cambridge to develop and evaluate new therapies for osteoarthritis, osteosarcoma and post-surgical pain.
Dr Lucy Grist - University of Surrey
Talk: Antibiotic related behaviours and phage therapy as an alternative antimicrobial in UK companion animal medicine
Dr Lucy Grist graduated from the University of Surrey in 2014 with a BSc in Veterinary Biosciences. During her undergraduate degree, she undertook a placement year with Fitzpatrick Referrals where she worked as a diagnostic microbiologist. Lucy continued to work in Veterinary diagnostics at The Royal Veterinary College in Hawkshead and then Hampden Veterinary Hospital in Buckinghamshire. She returned to Surrey in 2016 to undertake a PhD sponsored by the Humanimal Trust, during which she used a multidisciplinary approach to explore the role of behaviour in antimicrobial resistance (AMR) and antibiotic use amongst companion animal vets, and investigated the use of phage therapy as an alternative antimicrobial for canine patients. She completed her PhD in 2020 and is now working as a Research Fellow for Liphook Equine Hospital, where she is developing rapid diagnostics for equine diseases.
Dr Dan Horton MA VetMB MSc PhD FHEA MRCVS DipECZM - University of Surrey
Talk: The potential and pitfalls of translating between species: Oncolytic viruses for cancer treatment
Dr Dan Horton is a Reader In Veterinary Virology, Associate Dean Research and Innovation at the Faculty of Health and Medical Sciences, University of Surrey. Dr Horton graduated as a veterinarian from the University of Cambridge, UK and prior to joining the University of Surrey in 2014, worked at the Rabies Reference Laboratory at the UK Government’s Animal and Plant Health Agency. Dr Horton was an advisor to the UK Government’s Department for Environment, Food and Rural Affairs (Defra), Public Health England and the World Organisation for Animal Health (OIE). He has led multiple overseas assistance projects on rabies including in Africa and the Middle East. Dr Horton’s research group is focused on reducing the animal and human health burden caused by diseases that cross species barriers. Approaches include fundamental work on the evolution of viral pathogens, through to the applied aspects of control policy in national and international rabies projects. An area of particular importance is the wildlife-livestock-human interface and its role in the emergence of pathogens, recently supported by an Academy of Medical Sciences Springboard award. Previous work includes characterising novel BSL3 pathogens in vitro and in-vivo, as well as planning, undertaking and interpreting data from surveillance programs for zoonotic pathogens in wildlife and domestic animals. An additional and allied area of interest is building veterinary and laboratory capacity internationally with benefits for global biosecurity.
Professor Margaret Hall-Craggs - University College London (UCL)
Talk: Joint Odyssey; Finding inflammation with Magnetic Resonance Scans
Professor Margaret Hall-Craggs is Professor of Medical Imaging at UCL and Consultant Radiologist at University College London Hospitals NHS Foundation Trust (UCLH). Professor Hall-Craggs leads a research group investigating the imaging of inflammation in the musculosketetal system, mainly concentrating on inflammatory arthritis in adolescents. She is a Fellow of the International Society for Magnetic Resonance in Medicine (ISMRM), the Royal College of Radiologists Junior Radiologists’ Forum Trainer of the Year 2020, and Director of RADIANT, UK radiology trainee network for research. She is a member of the III Board for the UCLH Biomedical Research Centre.
SESSION THREE - One Medicine, One Team: How do we get human and veterinary medicine to communicate with each other?
Professor Roberto La Ragione BSc (Hons) MSc, PhD, FRSB CBiol, FIBMS, CSci, AECVM, FRCPATH, Hon. Assoc. RCVS - University of Surrey
Sandra Steele - University of Sydney
Talk: How can we promote collaborative practice between doctors and vets?
Having previously worked as a small animal practitioner, Sandra is a late-stage PhD student at the University of Sydney, Sydney School of Veterinary Science. Her research interests are in the areas of One Health, zoonoses and the establishment of pathways for collaborative practice between vets, medical practitioners and other One Health practitioners.
Dr James Yeates - Chief Executive, Cats Protection
Talk: Shared ethical challenges between human and veterinary medicine
Dr James Yeates is Chief Executive of Cats Protection, and vet (Diplomate of the Royal College of Veterinary Surgeons (RCVS) and European College of Animal Welfare and Behavioural Medicine, and Fellow of the Royal College of Veterinary Surgeons (FRCVS). Dr Yeates has a medical ethics degree and has written extensively on veterinary ethics. He was prior Chair of the British Veterinary Association’s Ethics and Welfare Group and Chief Veterinary Officer at the RSPCA.
Dr Ashish Ranjan - Director, Institute for Translational and Emerging Research in Advanced Comparative Therapy (INTERACT), Oklahoma State University
Talk: How the INTERACT Institute is bridging the gap between human and veterinary medicine
Dr Ashish Ranjan is the Professor and Endowed Chair in the College of Veterinary Medicine, Oklahoma State University (OSU). He also serves as the founding Director of the INTERACT program at OSU. INTERACT’s core mission is to promote one-health research. Dr Ranjan earned his veterinary medicine degree from Madras Veterinary College, in Chennai, India. He earned a PhD in Biomedical and Veterinary Sciences from Virginia Tech. Dr Ranjan then was a Visiting Fellow at the Centre for Interventional Oncology, Department of Radiology and Imaging Sciences at the National Institutes of Health (NIH). His research interests are in the application of device directed nanoparticles for solid tumour chemo-immunotherapy. His lab is actively engaged in preclinical and veterinary clinical trials, and receives funding from several federal, state and private sources. Dr Ranjan has received the NIH Merit, OSU distinguished faculty, regents research, and president’s fellow awards in recent years. He also serves in the Scientific Advisory Board of Focused Ultrasound Foundation, and several NIH panels.
PANEL DISCUSSION MEMBERS
We have an esteemed panel of doctors, vets and researchers who will be discussing the theme of how we can take a One Medicine approach forward in a post-COVID world to benefit both animal and human health.
Dr David Danson - President Elect, Royal Society of Medicine Comparative Medicine Section Council
Dr David Danson is currently President Elect of the Comparative Medicine Section at the Royal Society of Medicine in London. A vet, Dr Danson has spent the majority of his career in the veterinary pharmaceutical industry. He was a Member of Council at the Royal Veterinary College, where he was Chair of Ethics as well as Vice-Chair of Council for three years. He has represented the Royal Veterinary College on the Committee of University Chairs. In 2020, he was elected an Honorary Fellow of the Moredun Foundation in Edinburgh.
Dr James Bevan - Academic Foundation Doctor, Southampton General Hospital
Dr James Bevan is an academic foundation doctor at Southampton General Hospital. Prior to entering medical school, he graduated from Bath with a degree in chemistry and then worked as a sustainability consultant advising large corporates on their environmental and social footprints. He has worked on climate and health related projects at Harvard School of Public Health, Icahn School of Medicine at Mount Sinai and Public Health England.
Recently he has been leading the development of the International Medical Education Collaboration on Climate and Sustainability (IMECCS) and instigated the implementation of the 'Medicine, Climate Change and Sustainability Infusion Project' at Southampton Medical School. James has an academic interest in the link between environmental degradation/ preservation and global health. He plans to pursue a career investigating these interactions to help influence policy to create a greener, more equitable, healthier future for both humans and animals.
Associate Professor Benjamin Capps - Department of Bioethics, Faculty of Medicine, Dalhousie University, Canada
Associate Professor Benjamin Capps is a bioethicist and the Chair of the Human Genome Organisation’s (HUGO) Committee on Ethics, Law and Society. He is Head of the longitudinal Professional Competencies Unit in Dalhousie Medical School’s MD programme. Ben’s research interests include One Health ethics, genomics and ethics, and neuroethics. He is a member of the Editorial Board of the Cambridge Quarterly on Healthcare Ethics, Clinical Neuroethics. His work investigates bioethical matters relating to the nexus between applied ethics, normative theory and legal doctrine. His overall aim is to impart substantive theoretical guidance (or ethical grounding and critique) that has professional and social impact.
Dr Ellen Copson - Associate Professor and honorary consultant in Medical Oncology, University of Southampton and University Hospital Southampton
Dr Ellen Copson is Associate Professor and honorary consultant in Medical Oncology at the University of Southampton and University Hospital Southampton, where she specialises in treating breast cancer patients with systemic anti-cancer therapies. Following a PhD studying the molecular genetics of the BRCA1 gene, Dr Copson’s academic work now focuses on researching the genomic and modifiable host factors which influence the outcome of early breast cancer. She is a lead researcher on the POSH study, a large national cohort study of young breast cancer patients and is involved with a number of research studies investigating various aspects of breast cancer genomics and body composition/ nutrition in cancer. She is also principle investigator for many clinical trials in early and advanced breast cancer. Dr Copson has a particular interest in precision oncology and is Cancer lead of the Wessex Genomic Medical Centre, and chair of the National Oncogenetics Training Working Party. She was a member of the NIHR Breast Cancer Clinical Studies Group from 2013-2019 and set up the national Breast Cancer Trainees Research Collaborative Group which she remains senior chair of. Dr Copson is a member of the RCP Speciality Certificate Examination Board and the RCR Clinical Oncology Academic Committee. Locally Dr Copson is oncology lead for the University of Southampton medical degree.
Dr Michael James Francis PhD EurProBiol CBiol FRSB HonAssocRCVS - Managing Director, BioVacc Consulting Limited, UK
Dr Michael Francis has been responsible for veterinary and human vaccine projects against a broad range of infectious diseases. This has led to the development of commercial vaccines for all major veterinary livestock and pet species, utilising both conventional and novel technologies, including three coronavirus vaccines. Dr Francis is currently the Managing Director at BioVacc Consulting Ltd. He was elected as a Fellow of the Royal Society for Biology and awarded an Honorary Associateship of the Royal College of Veterinary Surgeons, in recognition of his contribution to the field of vaccine R&D and animal wellbeing. Michael is also currently Member of the Zoonoses and Emerging Livestock Systems Independent Programme Advisory Group (ZIPAG), a Member of the UK Vaccine Network, an Independent Member of the UK Science Partnership for Animal and Plant Health, a Board Member of the International Veterinary Vaccinology Network, a Trustee for the Jenner Vaccine Foundation, and a Member of the UK Zoonoses and a One Health Approach Advisory Group.
Professor Marc Lipman - Professor of Medicine, University College London
Professor Marc Lipman is Professor of Medicine at University College London, and Consultant in Respiratory and HIV Medicine at the Royal Free London NHS Foundation Trust. He is Lead for TB Services at the Royal Free and Director of UCL-TB, UCL’s cross-disciplinary TB research grouping. He chairs the British Thoracic Society TB Advisory Group, and NTM Network UK, the largest clinical research group on Non-Tuberculous Mycobacteria in the UK. He has served on national and international committees, including UK NICE TB Guideline Group and British HIV Association HIV/TB co-infection Working Party. His research focusses on mycobacterial disease, respiratory infection and HIV.
Professor Ali Mobasheri - Professor of Musculoskeletal Biology, Faculty of Medicine, University of Oulu, Finland
Visiting Professor, Harvard University, Boston, USA
Visiting Professor, Sun Yat-sen University, Guangdong, China
Professor Ali Mobasheri is President of the Osteoarthritis Research Society International (OARSI) and Professor of Musculoskeletal Biology in the Research Unit of Medical Imaging, Physics and Technology within the Faculty of Medicine at the University of Oulu in Finland. He also holds the position of Chief Researcher in the State Research Institute Centre for Innovative Medicine in Vilnius, Lithuania and is an Associate Professor in the Department of Orthopaedics and the Departments of Rheumatology and Clinical Immunology at University Medical Centre Utrecht in the Netherlands. He has authored more than 300 papers and served on several editorial boards. He was educated at Dulwich College London, Imperial College London, the University of Toronto and the University of Oxford where he obtained his doctorate from Wolfson College Oxford. His current H-index is 61 and he is ranked as one of the top 10 leading experts in the world on osteoarthritis on expertscape.com.
Dr Anna Radford - Consultant in Paediatric Surgery, Hull University NHS Trust and Leeds Children’s Hospital
Dr Anna Radford is a Consultant in Paediatric Surgery with a specialist interest in Paediatric Urology, working both at Hull University NHS Trust and Leeds Children’s Hospital. She is a Senior Clinical Lecturer at Hull York Medical School. Anna obtained a PhD in 2015 for her thesis entitled “Regenerative Medicine Applications in Paediatric Urology: Barriers and Solutions”. Her ongoing research activities continue in the areas of tissue engineering in the urinary tract, recurrent urinary tract infections in children, medical innovation in paediatrics and the neuropathic bladder. She sits on the “Young” Academic Working Group in Paediatric Urology in the European Association of Urology and reviews for several journals in the field of paediatric urology. Anna mentors young people from disadvantaged backgrounds who aspire to a career in medicine, as she was once in their shoes. She lives with Andy her long suffering partner of 14 years and her 11 year old sprocker Olly – who keeps her “sane-ish”.
Mary Ward - Veterinary Student, University of Glasgow School of Veterinary Medicine; Outgoing President, Glasgow University One Health Society
Mary Ward is a 4th year veterinary student at the University of Glasgow School of Veterinary Medicine. Mary is originally from Memphis, Tennessee and completed her undergraduate degree in Biological Sciences from the University of Connecticut. She is the out-going President of the Glasgow University One Health Society and is a firm believer in the importance of approaching my career from a “One Medicine” perspective. She considers that we all benefit significantly from learning from each other.
Dr Ashish Ranjan - Director, Institute for Translational and Emerging Research in Advanced Comparative Therapy (INTERACT), Oklahoma State University
Dr James Yeates - Chief Executive, Cats Protection
Humanimal Trust One Medicine Day Symposium 2021
Symposium Organising Committee, Email: Info@Humanimaltrust.org.uk